Recently, we showed that GSK3β could be persulfidated and that its persulfidation levels (as well as global persulfidation levels) decreased in cells, mouse and human brain samples of AD patients (Giovinazzo et al., 2021). This evidence concerns the gene GSK3B and Alzheimer disease.